Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F2H01
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,803
Award facts
- Contract value 100% obligated
- $11,803.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,803.24 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Monovisc 88 mg/4 ml syringes under a firm fixed-price delivery order. Ultimate completion date is March 9, 2026. Place of performance is Conshohocken, PA.
Quick answers
Who was awarded contract SPE2DR26F2H01?
SPE2DR26F2H01 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26F2H01 worth?
The government has obligated $11,803 on SPE2DR26F2H01.
Is contract SPE2DR26F2H01 an order under another contract?
Yes. SPE2DR26F2H01 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F2H01 competed?
The extent of competition for SPE2DR26F2H01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award